Characterization of antipsychotic utilization before clozapine initiation for individuals with schizophrenia: an innovative visualization of trajectories using French National Health Insurance data.

MLA

Laforgue, Edouard-Jules, et al. “Characterization of Antipsychotic Utilization before Clozapine Initiation for Individuals with Schizophrenia: An Innovative Visualization of Trajectories Using French National Health Insurance Data.” Epidemiology and Psychiatric Sciences, vol. 32, Sept. 2023, p. e59. EBSCOhost, https://doi.org/10.1017/S2045796023000732.

APA

Laforgue, E.-J., Istvan, M., Chaslerie, A., Artarit, P., Vallot, G., Jolliet, P., Grall-Bronnec, M., & Victorri-Vigneau, C. (2023). Characterization of antipsychotic utilization before clozapine initiation for individuals with schizophrenia: an innovative visualization of trajectories using French National Health Insurance data. Epidemiology and Psychiatric Sciences, 32, e59. https://doi.org/10.1017/S2045796023000732

Chicago

Laforgue, Edouard-Jules, Marion Istvan, Anicet Chaslerie, Pascal Artarit, Geneviève Vallot, Pascale Jolliet, Marie Grall-Bronnec, and Caroline Victorri-Vigneau. 2023. “Characterization of Antipsychotic Utilization before Clozapine Initiation for Individuals with Schizophrenia: An Innovative Visualization of Trajectories Using French National Health Insurance Data.” Epidemiology and Psychiatric Sciences 32 (September): e59. doi:10.1017/S2045796023000732.